» Articles » PMID: 35013705

Application of Bayesian Spatial-temporal Models for Estimating Unrecognized COVID-19 Deaths in the United States

Overview
Journal Spat Stat
Date 2022 Jan 11
PMID 35013705
Authors
Affiliations
Soon will be listed here.
Abstract

In the United States, COVID-19 has become a leading cause of death since 2020. However, the number of COVID-19 deaths reported from death certificates is likely to represent an underestimate of the total deaths related to SARS-CoV-2 infections. Estimating those deaths not captured through death certificates is important to understanding the full burden of COVID-19 on mortality. In this work, we explored enhancements to an existing approach by employing Bayesian hierarchical models to estimate unrecognized deaths attributed to COVID-19 using weekly state-level COVID-19 viral surveillance and mortality data in the United States from March 2020 to April 2021. We demonstrated our model using those aged years who died. First, we used a spatial-temporal binomial regression model to estimate the percent of positive SARS-CoV-2 test results. A spatial-temporal negative-binomial model was then used to estimate unrecognized COVID-19 deaths by exploiting the spatial-temporal association between SARS-CoV-2 percent positive and all-cause mortality counts using an excess mortality approach. Computationally efficient Bayesian inference was accomplished via the Polya-Gamma representation of the binomial and negative-binomial models. Among those aged years, we estimated 58,200 (95% CI: 51,300, 64,900) unrecognized COVID-19 deaths, which accounts for 26% (95% CI: 24%, 29%) of total COVID-19 deaths in this age group. Our modeling results suggest that COVID-19 mortality and the proportion of unrecognized deaths among deaths attributed to COVID-19 vary by time and across states.

Citing Articles

Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.

Paglino E, Lundberg D, Wrigley-Field E, Zhou Z, Wasserman J, Raquib R Proc Natl Acad Sci U S A. 2024; 121(6):e2313661121.

PMID: 38300867 PMC: 10861891. DOI: 10.1073/pnas.2313661121.


Excess Mortality in the United States, 2020-21: County-level Estimates for Population Groups and Associations with Social Vulnerability.

Kandula S, Keyes K, Yaari R, Shaman J medRxiv. 2024; .

PMID: 38293208 PMC: 10827264. DOI: 10.1101/2024.01.14.24301290.


Development of a Predictive Statistical Pharmacological Model for Local Anesthetic Agent Effects with Bayesian Hierarchical Model Parameter Estimation.

Ara T, Kitamura H Medicines (Basel). 2023; 10(11).

PMID: 37999201 PMC: 10672774. DOI: 10.3390/medicines10110061.


Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022.

Paglino E, Lundberg D, Zhou Z, Wasserman J, Raquib R, Luck A Sci Adv. 2023; 9(25):eadf9742.

PMID: 37352359 PMC: 10289647. DOI: 10.1126/sciadv.adf9742.


COVID-19 outbreaks analysis in the Valencian Region of Spain in the prelude of the third wave.

Fuente D, Hervas D, Rebollo M, Conejero J, Oliver N Front Public Health. 2022; 10:1010124.

PMID: 36466513 PMC: 9713945. DOI: 10.3389/fpubh.2022.1010124.


References
1.
Woolf S, Chapman D, Sabo R, Zimmerman E . Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021. JAMA. 2021; . PMC: 8019132. DOI: 10.1001/jama.2021.5199. View

2.
Cohen C, Simonsen L, Kang J, Miller M, McAnerney J, Blumberg L . Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis. 2010; 51(12):1362-9. PMC: 3106243. DOI: 10.1086/657314. View

3.
Weinberger D, Chen J, Cohen T, Crawford F, Mostashari F, Olson D . Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020. JAMA Intern Med. 2020; 180(10):1336-1344. PMC: 7330834. DOI: 10.1001/jamainternmed.2020.3391. View

4.
Vandoros S . Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales. Soc Sci Med. 2020; 258:113101. PMC: 7836531. DOI: 10.1016/j.socscimed.2020.113101. View

5.
Neal K, Ramsay S, Thomson B, Irving W . Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut. 2007; 56(8):1098-104. PMC: 1955506. DOI: 10.1136/gut.2006.113217. View